Fragile Histidine Triad (FHIT) Suppresses Proliferation and Promotes Apoptosis in Cholangiocarcinoma Cells by Blocking PI3K-Akt Pathway

Cholangiocarcinoma — Current Treatment Options

(2017) S. Friman   Scandinavian Journal of Surgery

ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer

(2013) Q Ye et al.   ONCOGENE

Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma

(2013) Kim Vaiphei   World Journal of Gastrointestinal Oncology

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

(2012) Irene Romero et al.   JOURNAL OF PATHOLOGY

The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway

(2012) Chan-Chan Lin et al.   PLoS One

Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro

(2011) Min Shi et al.   GYNECOLOGIC ONCOLOGY

Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells

(2010) D. K. Mishra et al.   MOLECULAR CANCER THERAPEUTICS

Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis

(2009) Cong Tang et al.   ANTI-CANCER DRUGS

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH